CHE Short Interest

Chemed Corporation (CHE) operates in the Healthcare sector, specifically the Medical - Care Facilities industry, with a market capitalization near $5.63B, listed on NYSE, employing roughly 15,695 people, carrying a beta of 0.54 to the broader market. Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. Led by Kevin J. McNamara, public since 1973-05-03.

Short interest is the total number of shares currently sold short and not yet covered, reported bi-monthly by FINRA. Days to cover (short interest divided by average daily volume) indicates how long it would take short sellers to close positions, with higher values signaling greater squeeze potential.

Settlement Date
2026-04-30
Short Interest
525.0K
Previous Short Interest
430.4K
Change
21.99%
Days to Cover
1.69
Avg Daily Volume
311.1K
Avg Days to Cover (24 reports)
2.95

Showing 24 bi-monthly FINRA short interest reports for Chemed Corporation.

Learn how short interest is reported and how to read the data →

Frequently asked CHE short interest questions

What is the current CHE short interest?
As of the Apr 30, 2026 settlement, Chemed Corporation (CHE) short interest is 525.0K shares, a +21.99% change from the prior period. FINRA publishes short interest twice monthly on the 15th and last business day of each month under Rule 4560.
What is the CHE days-to-cover ratio?
Days-to-cover is 1.69, calculated as short interest divided by average daily volume. It estimates how many trading days closing all short positions would consume given typical liquidity. Values above 5 days are commonly cited as elevated; values above 10 days are squeeze-relevant.
How does CHE short interest affect options pricing?
High short interest changes options pricing through three mechanics: borrow-rebate effects (synthetic long stock trades below frictionless put-call parity by approximately the borrow rebate when shares are hard-to-borrow), gamma-squeeze setup risk (if dealers are short gamma against retail call buying, dealer hedge flow can amplify upward moves), and elevated event-vol pricing on names with squeeze potential. See the canonical short-interest documentation for the full mechanism.